Scientific and medical news

New oral anticoagulants in the treatment of heparin- induced thrombocytopenia

22.01.20152905

There are little data on the efficacy of new oral anticoagulants (NOAC) in this setting.

University of Michigan hospital discharges patient with artificial heart

21.01.20151576

The University of Michigan Frankel Cardiovascular Center recently discharged a 24-year old patient with a total artificial heart, allowing him to return home without a human heart while he waits for a heart transplant.

Cerebrovascular disease often linked to Alzheimer’s disease

20.01.20152108

Cerebrovascular disease is often associated with Alzheimer’s disease, and especially with cognitive decline, according to researchers.

ANNEXA-R: Antidote to novel oral anticoagulant met primary endpoint

19.01.20152007

Portola Pharmaceuticals announced topline results of the phase 3 ANNEXA-R study demonstrating that andexanet alfa, an antidote to the anticoagulant effects of Factor Xa inhibitors, met the primary endpoint with high statistical significance.

New analysis finds no association between statins, cognitive impairment

16.01.20151885

A systematic review and meta-analysis of 25 randomized controlled trials yielded no significant association between statin therapy and cognitive impairment.

Delaying noncardiac surgery after stent implantation may reduce cardiac events

16.01.20151682

Risks associated with noncardiac surgery are highest in the first 6 months after coronary stent implantation, and a new study suggests that delaying noncardiac surgery for at least 6 months may yield improved outcomes in patients after stenting.

Alirocumab meets primary endpoints in ODYSSEY CHOICE trials

14.01.20152150

Sanofi and Regeneron Pharmaceuticals Inc. announced that the phase 3 ODYSSEY CHOICE I and CHOICE II trials had each met their primary efficacy endpoints for monthly treatment with alirocumab in patients with hypercholesterolemia.